Nephropathy is a serious end-stage kidney disease in patients with type 1 and 2 diabetes. To make matter worse, it is very challenging to impede its progression into its diabetes-associated kidney disease known as Diabetic Nephropathy (DN). This article focuses on the use of glycemic control as an intervention strategy against diabetic nephropathy and other diabetes-related complexities.
Diabetic Nephropathy or Diabetic Kidney Disease Diabetic Nephropathy (DN) is defined by specific pathologic structural and functional alterations in the kidneys of patients suffering from either type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Diabetic nephropathy affects 40 percent of people with diabetes and is characterized by its clinical presentations of proteinuria, hypertension, and progressive decline in kidney function. Diabetic Nephropathy Detection Strategy Earliest…
